Dr. Jeanne Bolger to chair Board of Directors of Belgium-bas

Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company.Last month, AstriVax closed its funding round - led by

Related Keywords

Leuven , Region Flamande , Belgium , Ireland , Irish , Ackermans Van Haaren , Kostenloser Wertpapierhandel , Johan Neyts , Jeanne Bolger , Hanne Callewaert , Kai Dallmeier , Glaxosmithkline , Ku Leuven Rega Institute , Johnson , V Bio Ventures , Astrivax Board , Rega Institute , Professor Johan Neyts , Flanders Future Techfund , Thuja Capital , Jeanne , Holger , Hair , Board , Directors , Ased , Vaccine , Technology , Company , Astrivax ,